Matches in DBpedia 2015-10 for { <http://dbpedia.org/resource/Peginesatide> ?p ?o }
Showing triples 1 to 85 of
85
with 100 triples per page.
- Peginesatide abstract "Peginesatide (INN/USAN, trade name Omontys, formerly Hematide), developed by Affymax and Takeda, is an erythropoietic agent, a functional analog of erythropoietin. It was approved by the U.S. Food and Drug Administration for treatment of anemia associated with chronic kidney disease (CKD) in adult patients on dialysis. On February 23, 2013, Affymax and Takeda issued a press release indicating that they were recalling all batches of peginesatide from the market. On June 16, 2014, Affymax and Takeda issued a press release stating that Takeda will work with the FDA to withdraw the peginesatide New Drug Application.Two randomized controlled trials published in 2013 found that the effectiveness of peginesatide was not inferior to epoetin for patients receiving dialysis (the EMERALD study), or to darbepoetin for patients with chronic kidney disease who were not receiving dialysis (the PEARL study). However, the safety endpoint of cardiovascular events and death was worse for peginesatide than for darbepoetin in the PEARL study.".
- Peginesatide atcPrefix "B03".
- Peginesatide atcSuffix "XA04".
- Peginesatide casNumber "913976-27-9".
- Peginesatide casSupplemental "(acetate)".
- Peginesatide chEBI "66889".
- Peginesatide iupacName "Poly(oxy-1,2-ethanediyl), α-hydro-ω-methoxy-, diester with 21N6,21'N6-{[(N2,N6-dicarboxy-(L)-lysyl-β-alanyl)imino]bis(1-oxo-2,1-ethanediyl)}bis[N-acetylglycylglycyl-(L)-leucyl-(L)-tyrosyl-(L)-alanyl-(L)-cysteinyl-(L)-histidyl-(L)-methionylglycyl-(L)-prolyl-(L)-isoleucyl-(L)-threonyl-3-(1-naphthalenyl)-(L)-alanyl-(L)-valyl-(L)-cysteinyl-(L)-glutaminyl-(L)-prolyl-(L)-leucyl-(L)-arginyl-N-methylglycyl-(L)-lysinamide]cyclic (6→15),(6'→15')-bis(disulfide)".
- Peginesatide wikiPageExternalLink london-2012-holding-back-the-hematide.
- Peginesatide wikiPageID "33989971".
- Peginesatide wikiPageLength "7961".
- Peginesatide wikiPageOutDegree "22".
- Peginesatide wikiPageRevisionID "673978164".
- Peginesatide wikiPageWikiLink Acetate.
- Peginesatide wikiPageWikiLink Affymax.
- Peginesatide wikiPageWikiLink Anemia.
- Peginesatide wikiPageWikiLink Atomic_mass_unit.
- Peginesatide wikiPageWikiLink Category:Antianemic_preparations.
- Peginesatide wikiPageWikiLink Category:Withdrawn_drugs.
- Peginesatide wikiPageWikiLink Chronic_kidney_disease.
- Peginesatide wikiPageWikiLink Darbepoetin_alfa.
- Peginesatide wikiPageWikiLink Dialysis.
- Peginesatide wikiPageWikiLink Epoetin_alfa.
- Peginesatide wikiPageWikiLink Erythropoiesis.
- Peginesatide wikiPageWikiLink Erythropoietin.
- Peginesatide wikiPageWikiLink Functional_analog.
- Peginesatide wikiPageWikiLink Hoffmann-La_Roche.
- Peginesatide wikiPageWikiLink Hoffmann–La_Roche.
- Peginesatide wikiPageWikiLink International_Nonproprietary_Name.
- Peginesatide wikiPageWikiLink Intravenous.
- Peginesatide wikiPageWikiLink Intravenous_therapy.
- Peginesatide wikiPageWikiLink KDa.
- Peginesatide wikiPageWikiLink Methoxy_polyethylene_glycol-epoetin_beta.
- Peginesatide wikiPageWikiLink Mircera.
- Peginesatide wikiPageWikiLink PEGylated.
- Peginesatide wikiPageWikiLink PEGylation.
- Peginesatide wikiPageWikiLink Polyethylene_glycol.
- Peginesatide wikiPageWikiLink Subcutaneous_injection.
- Peginesatide wikiPageWikiLink Takeda_Pharmaceutical_Company.
- Peginesatide wikiPageWikiLink United_States_Adopted_Name.
- Peginesatide wikiPageWikiLinkText "Peginesatide".
- Peginesatide wikiPageWikiLinkText "peginesatide".
- Peginesatide atcPrefix "B03".
- Peginesatide atcSuffix "XA04".
- Peginesatide casNumber "913976".
- Peginesatide chebi "66889".
- Peginesatide chemicalFormula "C231H350N62O58S6[C2H4O]n".
- Peginesatide chemspiderid "NA".
- Peginesatide hasPhotoCollection Peginesatide.
- Peginesatide iupacName "Poly, α-hydro-ω-methoxy-, diester with 21N6,21'N6-{[imino]bis}bis[N-acetylglycylglycyl-(L)-leucyl-(L)-tyrosyl-(L)-alanyl-(L)-cysteinyl-(L)-histidyl-(L)-methionylglycyl-(L)-prolyl-(L)-isoleucyl-(L)-threonyl-3--(L)-alanyl-(L)-valyl-(L)-cysteinyl-(L)-glutaminyl-(L)-prolyl-(L)-leucyl-(L)-arginyl-N-methylglycyl-(L)-lysinamide] cyclic ,-bis".
- Peginesatide iupharLigand "7447".
- Peginesatide legalUs "Rx-only".
- Peginesatide licenceUs "OMONTYS".
- Peginesatide molecularWeight "45".
- Peginesatide pregnancyUs "C".
- Peginesatide pubchemsubstance "124490628".
- Peginesatide routesOfAdministration Intravenous.
- Peginesatide routesOfAdministration Intravenous_therapy.
- Peginesatide routesOfAdministration Subcutaneous_injection.
- Peginesatide tradename "Omontys".
- Peginesatide wikiPageUsesTemplate Template:B03,_B05,_B06.
- Peginesatide wikiPageUsesTemplate Template:Drugbox.
- Peginesatide wikiPageUsesTemplate Template:Reflist.
- Peginesatide subject Category:Antianemic_preparations.
- Peginesatide subject Category:Withdrawn_drugs.
- Peginesatide hypernym Agent.
- Peginesatide type Article.
- Peginesatide type ChemicalSubstance.
- Peginesatide type Drug.
- Peginesatide type Article.
- Peginesatide type Chemical.
- Peginesatide type Drug.
- Peginesatide type Preparation.
- Peginesatide type ChemicalObject.
- Peginesatide type Thing.
- Peginesatide type Q8386.
- Peginesatide comment "Peginesatide (INN/USAN, trade name Omontys, formerly Hematide), developed by Affymax and Takeda, is an erythropoietic agent, a functional analog of erythropoietin. It was approved by the U.S. Food and Drug Administration for treatment of anemia associated with chronic kidney disease (CKD) in adult patients on dialysis. On February 23, 2013, Affymax and Takeda issued a press release indicating that they were recalling all batches of peginesatide from the market.".
- Peginesatide label "Peginesatide".
- Peginesatide sameAs Péginésatide.
- Peginesatide sameAs m.0hrgpdn.
- Peginesatide sameAs Peginesatid.
- Peginesatide sameAs Peginesatid.
- Peginesatide sameAs Q3662569.
- Peginesatide sameAs Q3662569.
- Peginesatide wasDerivedFrom Peginesatide?oldid=673978164.
- Peginesatide isPrimaryTopicOf Peginesatide.